![Rubén Díez Punzano](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Rubén Díez Punzano
Director/Miembro de la Junta en Telum Therapeutics SL .
Cargos activos de Rubén Díez Punzano
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Director/Miembro de la Junta | - | - |
Historial de carrera de Rubén Díez Punzano
Antiguos cargos conocidos de Rubén Díez Punzano.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Director Ejecutivo | 07/04/2015 | - |
Fundador | 07/04/2015 | - |
Estadísticas
Internacional
España | 3 |
Operativa
Chief Executive Officer | 1 |
Founder | 1 |
Director/Board Member | 1 |
Sectorial
Health Technology | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Ikan Biotech SL
![]() Ikan Biotech SL BiotechnologyHealth Technology Ikan Biotech SL engages in the design and development of xenograft models. Its Xenograft Model is a tumour model system to design and test the efficacy of potential drugs for the treatment of cancer. The company was founded by Rubén Díez Punzano and Roberto Díez-Martínez on April 7, 2015 and is headquartered in Noáin, Spain. | Health Technology |
Telum Therapeutics SL
![]() Telum Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Telum Therapeutics SL is a Spanish biotechnology company that specializes in drug discovery and the use of Innovative Phage Lytic Proteins as antibiotics. The company is based in Noáin, Spain. The company has specific programs to treat serious multidrug-resistant Gram-negative infections caused by Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa. Telum Therapeutics leverages the power of nature through the understanding of biological controls exerted by bacteriophages to balance bacterial ecosystems. The CEO of the company is Roberto Díez-Martínez. | Commercial Services |
- Bolsa de valores
- Insiders
- Rubén Díez Punzano
- Experiencia